Food and Drug Administration
February 8, 2005
Slides
Update on BSE Surveillance in the US, Lisa Ferguson, DVM, USDA (PDF) (PPT)
Topic #1 - Possible vCJD Risk From Investigational Coagulation Factor X! Manufactured Before 2998 From Plasma of Donors Residing in the United Kingdom
Introduction, Mark Weinstein, PhD, FDA (HTM) (PPT)
Risk Assessment Methods, Assumptions and Public Health Actions in the UK, Kate Soldan, PhD & Anna Molesworth, MSc, UK HEalth Protection Agency (HTM) (PPT)
Draft Risk Assessment for UK Manufactured Factor X! and Potential vCJD Exposure, Steven Anderson, PhD, MPP, FDA (HTM) (PPT)
Instrtument Management in Surgery and Dentistry Current CDC Recommendations, Lynne Sehulster, PhD, M(ASCP), CDC (HTM) (PPT)
Topic #2 - Risk Assessment Models for Potential Risk of Exposure to Variant Creutzfeldt-Jakob Disease (vCJD) Agent in Plasma Products
Assessment for Potential Risk of Exposure to the vCJD Agent in Plasma Products, Dorothy Scott, MD, FDA (HTM) (PPT)
TSE Clearance in Plasma Derivatives, Dorothy Scott, MD, FDA (HTM) (PPT)
Preliminary Risk Assessment Model for US Plasma Derivatives and vCJD, Steven Anderson, PhD, MPP, FDA (HTM) (PPT)
Topic #3 - Potential Deferral of Blood and Plasma Donors for History of Transfusion in European Countries
Introduction, Alan Williams, PhD, FDA (HTM) (PPT)
Blood-Born vCJD Risk: in UK and Other European Populations, Sheila Bird, MA, PhD, Institute of Public Health, UK (HTM) (PPT)
Deferral of Blood and Plasma Donors for History of Transfusion in GSE Countries of Europe (HTM) (PPT)
Open Public Hearing
List of Speakers (HTM) (PDF) (Word)
Removal of Infectious Prions From Red Cell Concentrates, Samuel Coker, PhD, Pall Medical (HTM) (PPT)
Federal Meat Inspectors: USDA Policies on Mad Cow Threaten Public Health, American Corn Growers Assoc., et. al. (PDF)
Statement of AABB Regarding Deferral of Blood and Plasma Donors for History of Transfusion in France and Other European Countries, Presented by M. Carr-Greer, MT (ASCP) SBB (HTM) (PDF) (Word)
Statement of America's Blood Centers, Presented by G. Fitzpatric (HTM) (PDF) (Word)
Statement of New York Blood Center, Presented by Richard Davey, MD (PDF)
Public Comment Regarding Januaru 19, 2005 Federal Register, Vol. 70, No, 12, Page 3045 (PDF)